Hi John435 - what is your take on CJO being able to earn up to 75% of SMD's molybdenum-copper-gold-rhenium deposit holding at Kalman South by completing a bankable feasibility study - they have obviously walked away from this and yet the ground yielded results comparable to Ivanhoe's ground due east which Ivanhoe consider to be top rate( I don't know how far away but as far as distances go up north probably a near neighbor?).
Anyway, if you were SMD's management would you approach Ivanhoe because:
1) they have the money to develop whilst we concentrate on the copper/gold at Mount Remarkable and as our resources are limited or
2)seek to buy it back by getting another well heeled partner to join the fold - I suppose our large Korean shareholder would have something to say in this regard.
I am mulling this over on my third glass of red because I don't see anyway forward at Kalman South with CJO looking like they have jumped ship: I suppose it would cost a lot of dollars to develop the field.
So, it really looks to me like Kalman South goes on the back-burner until after the next GFC hit when these commodities will really take-off.
Anyway, the important thing to my mind is the Mount Remarkable resource - some of those copper hits are way above the current big mines average and the next drilling reports are awaited with interest.
- Forums
- ASX - By Stock
- 2 significant regional faults ++
Hi John435 - what is your take on CJO being able to earn up to...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LAT (ASX) to my watchlist
(20min delay)
|
|||||
Last
14.0¢ |
Change
-0.005(3.45%) |
Mkt cap ! $19.96M |
Open | High | Low | Value | Volume |
13.5¢ | 15.0¢ | 13.5¢ | $12.40K | 85.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 45000 | 13.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
14.5¢ | 56810 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 45000 | 0.135 |
3 | 270000 | 0.130 |
1 | 7000 | 0.125 |
1 | 100000 | 0.110 |
2 | 30000 | 0.105 |
Price($) | Vol. | No. |
---|---|---|
0.145 | 56810 | 1 |
0.150 | 10494 | 2 |
0.155 | 41748 | 1 |
0.160 | 105677 | 4 |
0.165 | 38131 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
LAT (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online